Publication | Open Access

In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of β2-glycoprotein I: proof of concept

Vivo InhibitionImmunologyAntiphospholipid Antibody-induced PathogenicityImmunodominancePeptide TherapeuticAntibody ScreeningAutoimmunityHumoral ImmunityPeptide TherapeuticsImmune FunctionAntibody EngineeringImmunochemistryAntigen ProcessingImmunotherapyMedicineAntigenic TargetAntibody Biology